Literature DB >> 6086177

In vitro study on contribution of oxidative metabolism of isolated rabbit heart mitochondria to myocardial reperfusion injury.

H Otani, H Tanaka, T Inoue, M Umemoto, K Omoto, K Tanaka, T Sato, T Osako, A Masuda, A Nonoyama.   

Abstract

The present study was performed to clarify oxygen-induced damage following myocardial reperfusion, using three mitochondrial preparations from isolated rabbit hearts (nonischemic hearts and those subjected to 40 and 90 minutes of normothermic global ischemia). The viability of mitochondria was evaluated by adenosine triphosphate generation. The extent of mitochondrial injury produced by reactive oxygen metabolism was assessed by the intensity of hydroxyl radical signal detected with electron spin resonance spectroscopy and the reduction of coenzyme Q10 level. The greatest oxygen-induced injury was observed in 40-minute ischemic mitochondria exposed to pure oxygen. The use of superoxide dismutase and catalase satisfactorily prevented the oxygen-induced injury. Moreover, the net adenosine triphosphate generation of the 40-minute ischemic mitochondria was comparable to that of the nonischemic mitochondria without the enzymes. These results suggest that reperfusion of the ischemic myocardium with viable mitochondria is deleterious, because mitochondria are susceptible to injury resulting from oxidative metabolism, and that the use of superoxide dismutase, together with catalase, is beneficial for the restoration of cardiac function after ischemia.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6086177     DOI: 10.1161/01.res.55.2.168

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  31 in total

1.  Oxygen radicals generated at reflow induce peroxidation of membrane lipids in reperfused hearts.

Authors:  G Ambrosio; J T Flaherty; C Duilio; I Tritto; G Santoro; P P Elia; M Condorelli; M Chiariello
Journal:  J Clin Invest       Date:  1991-06       Impact factor: 14.808

2.  Uncoupling of mitochondrial oxidative phosphorylation alters lipid peroxidation-derived free radical production but not recovery of postischemic rat hearts and post-hypoxic endothelial cells.

Authors:  I E Blasig; B F Dickens; W B Weglicki; J H Kramer
Journal:  Mol Cell Biochem       Date:  1996 Jul-Aug       Impact factor: 3.396

Review 3.  Calpain system and its involvement in myocardial ischemia and reperfusion injury.

Authors:  Christiane Neuhof; Heinz Neuhof
Journal:  World J Cardiol       Date:  2014-07-26

4.  Tolerance of myocardium of aged animals to repeated oxygen deficiency.

Authors:  H M Hoffmeister; L Seipel
Journal:  Basic Res Cardiol       Date:  1992 Mar-Apr       Impact factor: 17.165

Review 5.  Mitochondrial reactive oxygen species (ROS) and ROS-induced ROS release.

Authors:  Dmitry B Zorov; Magdalena Juhaszova; Steven J Sollott
Journal:  Physiol Rev       Date:  2014-07       Impact factor: 37.312

Review 6.  Use of hypothermia in the intensive care unit.

Authors:  Jesse J Corry
Journal:  World J Crit Care Med       Date:  2012-08-04

Review 7.  Occurrence of oxidative stress during myocardial reperfusion.

Authors:  R Ferrari; C Ceconi; S Curello; A Cargnoni; F De Giuli; O Visioli
Journal:  Mol Cell Biochem       Date:  1992-04       Impact factor: 3.396

8.  Effects of pharmacological preconditioning by emodin/oleanolic acid treatment and/or ischemic preconditioning on mitochondrial antioxidant components as well as the susceptibility to ischemia-reperfusion injury in rat hearts.

Authors:  Ying Du; Kam Ming Ko
Journal:  Mol Cell Biochem       Date:  2006-04-01       Impact factor: 3.396

9.  Chemiluminescence of ischaemic and reperfused intestine in vivo.

Authors:  E J Roldán; C R Pinus; J F Turrens; A Boveris
Journal:  Gut       Date:  1989-02       Impact factor: 23.059

Review 10.  Regulated production of free radicals by the mitochondrial electron transport chain: Cardiac ischemic preconditioning.

Authors:  Satoshi Matsuzaki; Pamela A Szweda; Luke I Szweda; Kenneth M Humphries
Journal:  Adv Drug Deliv Rev       Date:  2009-08-26       Impact factor: 15.470

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.